- Home
- Our Company
- Discover J&J
- Code of Business Conduct
Code of
Business Conduct
At Johnson & Johnson, we believe acting ethically and responsibly is not only the right thing to do, but also the right thing to do for our business. Our Johnson & Johnson Code of Business Conduct ensures that we hold ourselves and how we do business to a high standard, allowing us to fulfill our obligations to the many stakeholders we serve.
Effective May 16, 2024, Johnson & Johnson amended its Code of Business Conduct to provide enhanced guidance on addressing the evolving business environment, reflecting our commitment to compliance and responsible operations.
Effective May 16, 2024, Johnson & Johnson amended its Code of Business Conduct to provide enhanced guidance on addressing the evolving business environment, reflecting our commitment to compliance and responsible operations.
Our Credo Integrity Line
Our Credo Integrity Line is an integral component of our strong culture of integrity at Johnson & Johnson. It provides a channel for anyone (including employees, business partners, customers, consumers and others) to report potential violations of the Code of Business Conduct, other company policies or applicable laws and regulations in our countries of operation. Our Credo Integrity Line is available 24 hours a day, 7 days a week and in 24 languages.
Go to the Our Credo Integrity Line website for more information including directions for filing concerns digitally or by phone.
Go to the Our Credo Integrity Line website for more information including directions for filing concerns digitally or by phone.
Additional policies & resources
The values and principles spelled out in Our Credo serve as our compass; the Johnson & Johnson Code of Business Conduct is the road map that helps us stay on course with those values. The Code sets requirements for business conduct and serves as a foundation for our Company policies, procedures and guidelines, all of which provide additional guidance on expected behaviors.
Our Credo
The values that guide our decision-making are spelled out in Our Credo. Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first.
Robert Wood Johnson, former chairman from 1932 to 1963 and a member of the Company’s founding family, crafted Our Credo himself in 1943, just before Johnson & Johnson became a publicly traded company. This was long before anyone ever heard the term “corporate social responsibility.” Our Credo is more than just a moral compass. We believe it’s a recipe for business success. The fact that Johnson & Johnson is one of only a handful of companies that have flourished through more than a century of change is proof of that.
Robert Wood Johnson, former chairman from 1932 to 1963 and a member of the Company’s founding family, crafted Our Credo himself in 1943, just before Johnson & Johnson became a publicly traded company. This was long before anyone ever heard the term “corporate social responsibility.” Our Credo is more than just a moral compass. We believe it’s a recipe for business success. The fact that Johnson & Johnson is one of only a handful of companies that have flourished through more than a century of change is proof of that.
Discover
J&J
Every day, our more than 150,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.
Our Societal Impact
Johnson & Johnson’s ESG strategy aims to improve access, create healthier communities, and put a healthy mind, body and environment within reach of all.
More from Johnson & Johnson
This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others
Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.
After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists
Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.
How Johnson & Johnson is working to get medications to people around the world who need them most
In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.